The

Medical Director

is responsible for the strategic leadership, business and resource planning, team management, and overall performance of the Medical Affairs function in Thailand for

OBU, Rare Diseases, and Diagnostics.

The role focuses on maximizing business opportunities, mitigating risks, and strengthening AstraZeneca's scientific leadership through trusted partnerships with internal and external stakeholders, including healthcare professionals, Key External Experts (KEEs), clinical experts, and regulatory authorities.

The role also leads the Nominated Signatory function for the review of country activities and promotional materials, and oversees Medical Information, Patient Safety, and Pharmacovigilance within the market.

Typical Accountabilities:

Senior leader accountable for the development of the complete strategy for the Medical Affairs area(s) in line with the global/regional/area/local strategy and objectives.

Ensures that the strategy is cascaded throughout the function and operational plans and individual objectives are established.

Acts as the expert in the Medical Affairs subject area, both internally and externally, with knowledge that spans the complete function.

Responsible for ongoing management of the function, ensuring performance is achieved against goals and resources are managed effectively to deliver business outcomes.

Impact directly on the functional area through the results achieved by the department through the achievement of strategic objectives.

Oversees the development of optimal registration plans (registration of new products, line extensions, and addition of new indications), in conjunction with regulations and AstraZeneca policy, to support the achievements of AstraZeneca's strategic objectives.

Ensures that tactical leadership decisions are enforced in order for the business to achieve its objectives.

Coaches and delivers effect performance to direct and indirect reports creating a supportive work environment where everyone has the opportunity to fulfil their potential.

Determines resource needs and manages budget.

Ensures that all Medical Affairs initiatives and activities comply with regulations and AstraZeneca policy.

Communicate with Key External Experts (KEEs), prominent academic and clinical investigators, and leaders of the medical community who are willing to assist in the evaluation of AstraZeneca products in line with company's/brand team objectives.

Work with brand teams to provide clinical expertise/input into strategic and tactical decisions in support of AstraZeneca products.

Represent AstraZeneca at national meetings and national organizations related to Medical Affairs area(s) and is a spokesperson for the company's medical affairs-related issues.

Qualifications:

Advanced scientific or healthcare degree required, with preference for

MD, PharmD, PhD, MSc Pharmacy, or equivalent

Extensive senior-level experience in

Medical Affairs

within the pharmaceutical industry, including strategic leadership at country or regional level.

Demonstrated success in leading high-performing teams and shaping Medical Affairs strategy across complex or specialty portfolios.

Strong external credibility with

KEEs, healthcare professionals, academic leaders, and regulatory stakeholders

Deep understanding of

medical governance, compliance, pharmacovigilance, patient safety

, and local regulatory frameworks.

Experience in promotional material review and

Nominated Signatory

accountability is strongly preferred.

Strong business acumen, strategic planning capability, and experience managing budgets and organizational resources.

Excellent leadership, influencing, communication, and stakeholder engagement skills.

Fluency in

Thai and English

Date Posted

05-āļŠ.āļ„.-2026

Closing Date

30-āļ.āļĒ.-2026

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

āļ›āļĢāļ°āļŠāļšāļāļēāļĢāļ“āđŒāļ—āļĩāđˆāļˆāļģāđ€āļ›āđ‡āļ™
  • āđ„āļĄāđˆāļĢāļ°āļšāļļāļ›āļĢāļ°āļŠāļšāļāļēāļĢāļ“āđŒāļ‚āļąāđ‰āļ™āļ•āđˆāļģ
āđ€āļ‡āļīāļ™āđ€āļ”āļ·āļ­āļ™
  • āļŠāļēāļĄāļēāļĢāļ–āļ•āđˆāļ­āļĢāļ­āļ‡āđ„āļ”āđ‰
āļŠāļēāļĒāļ‡āļēāļ™
  • āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļ­āļēāļ§āļļāđ‚āļŠ
āļ›āļĢāļ°āđ€āļ āļ—āļ‡āļēāļ™
  • āļ‡āļēāļ™āļ›āļĢāļ°āļˆāļģ

āđ€āļāļĩāđˆāļĒāļ§āļāļąāļšāļšāļĢāļīāļĐāļąāļ—

āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™:2000-5000 āļ„āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļšāļĢāļīāļĐāļąāļ—:āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒ / āļāļēāļĢāļˆāļąāļ”āļˆāļģāļŦāļ™āđˆāļēāļĒ
āļ—āļĩāđˆāļ•āļąāđ‰āļ‡āļšāļĢāļīāļĐāļąāļ—:āļāļĢāļļāļ‡āđ€āļ—āļž
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒ:astrazeneca.com
āļāđˆāļ­āļ•āļąāđ‰āļ‡āđ€āļĄāļ·āđˆāļ­āļ›āļĩ:1999

AstraZeneca pharmaceuticals, one of the world's leading pharmaceutical companies, welcomes you to be a part of our vision to research and develop new medical advances to enhance the quality of life around the world. If you are interested in joining our leading pharmaceutical team at AstraZeneca, ple ... āļ­āđˆāļēāļ™āļ•āđˆāļ­

āļĢāđˆāļ§āļĄāļ‡āļēāļ™āļāļąāļšāđ€āļĢāļē: We recognize that our people are our greatest asset. We foster a culture of lifelong learning and are committed to our employees' well-being. We value an innovative and collaborative environment, encouraging everyone to contribute fresh perspectives. We are dedicated to creating a great place to wor ... āļ­āđˆāļēāļ™āļ•āđˆāļ­

āļŠāļģāļ™āļąāļāļ‡āļēāļ™āđƒāļŦāļāđˆ: 173/20 ASIA CENTER BUILDING THANON SATHORN TAI
Display map
āļ—āļĩāđˆ WorkVenture āđ€āļĢāļēāđƒāļŦāđ‰āļĄāļđāļĨāđ€āļŠāļīāļ‡āđ€āļāļĩāđˆāļĒāļ§āļāļąāļšāļšāļĢāļīāļĐāļąāļ— āđāļ­āļŠāļ•āļĢāđ‰āļēāđ€āļ‹āļ™āđ€āļ™āļāđ‰āļē (āļ›āļĢāļ°āđ€āļ—āļĻāđ„āļ—āļĒ) āļˆāļģāļāļąāļ” āđ‚āļ”āļĒāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡ āļ•āļąāđ‰āļ‡āđāļ•āđˆāļ āļēāļžāļšāļĢāļĢāļĒāļēāļāļēāļĻāļāļēāļĢāļ—āļģāļ‡āļēāļ™ āļĢāļđāļ›āļ–āđˆāļēāļĒāļ‚āļ­āļ‡āļ—āļĩāļĄāļ‡āļēāļ™ āđ„āļ›āļˆāļ™āļ–āļķāļ‡āļĢāļĩāļ§āļīāļ§āđ€āļŠāļīāļ‡āļĨāļķāļāļ‚āļ­āļ‡āļāļēāļĢāļ—āļģāļ‡āļēāļ™āļ—āļĩāđˆāļ™āļąāđˆāļ™ āļ‹āļķāđˆāļ‡āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļļāļāļ­āļĒāđˆāļēāļ‡āļšāļ™āļŦāļ™āđ‰āļēāļ‚āļ­āļ‡āļšāļĢāļīāļĐāļąāļ— āđāļ­āļŠāļ•āļĢāđ‰āļēāđ€āļ‹āļ™āđ€āļ™āļāđ‰āļē (āļ›āļĢāļ°āđ€āļ—āļĻāđ„āļ—āļĒ) āļˆāļģāļāļąāļ” āļĄāļĩāļžāļ™āļąāļāļ‡āļēāļ™āļ—āļĩāđˆāļāļģāļĨāļąāļ‡āļ—āļģāļ‡āļēāļ™āļ—āļĩāđˆāļšāļĢāļīāļĐāļąāļ— āđāļ­āļŠāļ•āļĢāđ‰āļēāđ€āļ‹āļ™āđ€āļ™āļāđ‰āļē (āļ›āļĢāļ°āđ€āļ—āļĻāđ„āļ—āļĒ) āļˆāļģāļāļąāļ” āļŦāļĢāļ·āļ­āđ€āļ„āļĒāļ—āļģāļ‡āļēāļ™āļ—āļĩāđˆāļ™āļąāđˆāļ™āļˆāļĢāļīāļ‡āđ† āđ€āļ›āđ‡āļ™āļ„āļ™āđƒāļŦāđ‰āļ‚āđ‰āļ­āļĄāļđāļĨāļˆāļĢāļīāļ‡āļŠāļĄāļąāļ„āļĢāļ‡āļēāļ™ āļšāļĩāļ­āļĩāļ‹āļĩ āđ€āļ—āđ‚āļĢāļŠāļĄāļąāļ„āļĢāļ‡āļēāļ™ āđāļ­āļ„āļĄāļĩāđˆ āļāļēāļĢāđŒāđ€āļĄāļ™āļ—āđŒāļŠāļĄāļąāļ„āļĢāļ‡āļēāļ™ āļ„āļēāđ‚āļ­āļŠāļĄāļąāļ„āļĢāļ‡āļēāļ™ āļĨāļĩāļŸāļŸāļ­āļĢāđŒāļ‹